Insitro

Founded: 2018 · South San Francisco, CA, United States · 201-500 employees · Private

About Insitro

Insitro is a machine learning-enabled drug discovery and development company that integrates multimodal data from human cohorts and cellular models with the power of AI and machine learning. The company aims to uncover genetic targets and new therapeutic hypotheses to accelerate the discovery and development of novel medicines.

Company Details

Website: https://www.insitro.com
Funding: Series C
Total Raised: $643M
LinkedIn: https://www.linkedin.com/company/insitro

Specializations

AI/ML
Drug Discovery
Biotechnology
Life Sciences
Machine Learning

Products & Solutions (4)

Product	Category	Sub-Category	Description
ChemML Discovery Platform	research-development	Drug Discovery AI	Accelerating drug discovery through chemistry machine learning and strategic collaborations.
Insitro Platform	research-development	Drug Discovery AI	ML-driven drug target discovery and validation
POSH Platform	research-development	Drug Discovery AI	AI-powered platform for gene function reconstruction and accelerated drug discovery.
TherML™ Platform	research-development	Drug Discovery AI	End-to-end, modality-agnostic system for designing small molecules, antibodies, oligonucleotides, and biologics.